Stock Analysis on Net

Pfizer Inc. (NYSE:PFE)

Analysis of Bad Debts

Microsoft Excel

Allowance for doubtful accounts receivable (bad debts) is a contra account which reduce the balance of the company gross accounts receivable. The relationship between the allowance and the balance in receivables should be relatively constant unless there is a change in the economy overall or a change in customer base.


Allowance for Doubtful Accounts Receivable

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Allowance for doubtful accounts 438 470 449 492 508
Trade accounts receivable, gross 11,901 11,647 11,401 11,971 8,438
Financial Ratio
Allowance as a percentage of trade accounts receivable, gross1 3.68% 4.04% 3.94% 4.11% 6.02%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Allowance as a percentage of trade accounts receivable, gross = 100 × Allowance for doubtful accounts ÷ Trade accounts receivable, gross
= 100 × 438 ÷ 11,901 = 3.68%

Financial ratio Description The company
Allowance as a percentage of trade accounts receivable, gross Allowance for doubtful accounts divided by the gross accounts receivable. Pfizer Inc. allowance as a percentage of trade accounts receivable, gross increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.